Washington: The FDA has approved the immediate use of Johnson & Johnson’s single-dose Covid vaccine. The vaccine will soon be available in the US.
Studies have shown that this vaccine is effective in preventing the development of new forms of Kovid. It is hoped that the delivery of the vaccine will be expedited as it is a single dose.
US President Joe Biden has said that this is a crucial step towards ending the Kovid crisis.
The effectiveness of Johnson & Johnson’s single dose vaccine is 85.8% in those with Covid Criticism. The study found that the study was 81.7 percent effective in Africa and 87.6 percent effective in Brazil.
So far, 5.10 lakh people have lost their lives in the United States alone since Kovid. It was in this context that the United States approved the third vaccine. Vaccination will begin immediately in the country if approved.
Vaccine doses will be delivered to the country from Monday. Johnson & Johnson has sought permission from the World Health Organization for the immediate use of the wax in Europe.
Content Highlights: US Clears Johnson & Johnson Single-Shot Covid Vaccine For Emergency Use
–
– .
